Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity - Concepedia

Concepedia

Publication | Closed Access

Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity

48

Citations

16

References

1994

Year

Christine Galustian, Sharmila Foulds, Julian F. Dye, P J Guillou

Immunopharmacology

Tumor BiologyMedicineGlycosylation InhibitorTumour SusceptibilityImmunologyImmune Checkpoint InhibitorAnti-cancer AgentMetronomic ChemotherapyImmunotherapyPharmacologyNk CytotoxicityCancer Research

References

	Year	Citations

Page 1